Double-Dummy Clinical Trial
Jump to navigation
Jump to search
A Double-Dummy Clinical Trial is a Crossover Clinical Trial that is Double-Blinded Clinical Trial for retaining the blind when administering supplies.
- Context:
- It requires that the two treatments cannot be made identical.
- Example(s):
- Counter-Example(s):
- See: Unblinding Clinical Trial Task, Clinical Trial Design, Treatment Group, Control Group, Confirmation Bias, Medical Bias, Clinical Trial Protocol, Good Clinical Practice.
References
2021
- (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research#D Retrieved:2021-12-18.
- QUOTE: Double-dummy
- A technique for retaining the blind when administering supplies in a clinical trial, when the two treatments cannot be made identical. Supplies are prepared for Treatment A (active and indistinguishable placebo) and for Treatment B (active and indistinguishable placebo). Subjects then take two sets of treatment; either A (active) and B (placebo), or A (placebo) and B (active). (ICH E9)
- QUOTE: Double-dummy